Pharmacokinetics and Metabolism Study of Radiolabeled BMS-986142 in Healthy Male Subjects
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
This is an open-label, single-dose, study in healthy males. The primary objective is to
assess the pharmacokinetics (PK), metabolism, and routes of elimination of a single oral dose
of radiolabeled BMS-986142 in healthy male subjects.